No evidence for constitutional ATM mutation in breast/gastric cancer families

International Journal of Oncology

Volumn 12, Issue 6, 1998, Pages 1385-1390

  Bay, Jacques Olivier ^a   Grancho, Maria ^a   Pernin, David ^a   Presneau, Nadège ^a   Rio, Pascale ^a   Tchirkov, Andrei ^b   Uhrhammer, Nancy ^c   Verrelle, Pierre ^a   Gatti, Richard A ^d   Bignon, Yves Jean ^a  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ataxia Telangiectasia; Breast cancer; Family; Gastric cancer; Heterozygote

Indexed keywords

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER FAMILY; CANCER RISK; CANCER SUSCEPTIBILITY; CEREBELLAR ATAXIA; CHROMOSOME 11Q; CLINICAL ARTICLE; CLINICAL FEATURE; DNA SEQUENCE; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; IMMUNE DEFICIENCY; PRIORITY JOURNAL; STOMACH CANCER;

EID: 13144255722     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.6.1385     Document Type: Article

References (39)

1. Gatti RA, Boder E, Vinters HV, Sparkes RS, Norman A and Lange K: Ataxia-telangicctasia: an inter disciplinary approach to pathogenesis. Medicine 70: 99-117, 1991.
2. Shiloh Y and Rotman G: Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency and cancer to cell cycle checkpoint. J Clin Immunol 16: 254-260, 1996.
3. Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, Ersoy F, Foroud T, Jasper NGJ, Lange K, Lahtrop GM, Leppert M, Nakamura Y, O'Connell P, Paterson M, Salser W, Sanal O, Silver J, Sparkes RS, Susi E, Weeks DE, Wei S, White R and Yoder F: Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336: 577-580, 1988.
4. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Seez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y: A single gene with a product similar to PI-3 kinase and Rad 3+ is mutated in ataxia-telangiectasia. Science 268: 1749-1753, 1995.
5. Savistky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y and Rotman G: The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4: 2025-2032, 1995.
6. Uziel T, Savitsky K, Platzer M, Ziv Y, Helbitz T, Rosenthal A, Nehls M, Boehm T, Shiloh Y and Rotman G: Genomic organization of the ATM gene. Genomics 33: 317-320, 1996.
7. Chen G and Lee Y-H-P: The product of the ATM gene is a 370-kd nuclear phosphoprotein. J Biol Chem 271: 33693-33697, 1996.
8. Jung M, Kondratyev A, Lee SA, Dimtchev A and Dritschilo A: ATM gene product phosphorylates IκB-a. Cancer Res 57: 24-27, 1997.
9. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, Smith S, Chessa L, Jorgensen TJ, Harnik R, Frydman M, Sanal O, Portnoi S, Goldwicz Z, Jaspers NGJ, Gatti RA, Lenoir G, Lavin MF, Tatsumi K, Wegner RD, Shiloh Y and Bar-Shira A: Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet 5: 433-439, 1996.
10. Telatar M, Wang Z, Udar N, Liang T, Bernatowska-Matuszkiewicz E, Lavin M, Shiloh Y, Concannon P, Good RA and Gatti RA: Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. Am J Hum Genet 59: 40-44, 1996.
11. Zakian VA: ATM-related genes: what do they tell us about functions of the human gene? Cell 82: 685-687, 1995.
12. Meyn MS: Ataxia-telangiectasia and cellular response to DNA damage. Cancer Res 55: 5991-6000, 1995.
13. Morrell D, Cromartie E and Swift M: Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 77: 89-92, 1986.
14. Taylor AMR, Metcalfe JA, Thick J and Mak YF: Leukemia and lymphoma in ataxia-telangiectasia. Blood 87: 423-438, 1996.
15. Taylor AMR: Ataxia-telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer. Br J Cancer 66: 5-9, 1992.
16. Swift M: Genetic aspects of Ataxia-Telangiectasia. In: Advances in Neurology. Harding AE and Deufel T (eds.) Raven Press, New York, pp 115-126, 1993.
17. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D and Wynshaw-Boris A: ATM-deficient mice, a paradigm of ataxia-telangiectasia. Cell 86: 159-171, 1996.
18. Swift M, Morrell D, Massey RB and Chase CL: Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325: 1831-1836, 1991.
19. Swift M, Reitnauer PJ, Morrell D and Chase CL: Breast and other cancers in families with ataxia-telansiectasia. N Engl J Med 316: 1289-1294, 1987.
20. Pippard EC, Hall AJ, Barker DJP and Bridges BA: Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 118: 2929-2932, 1988.
21. Borresen AL, Anderson TI, Treti S, Heiberg A and Moller P: Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosomes Cancer 2: 339-340, 1990.
22. Easton DF: Cancer risks in ataxia-telangiectasia heterozygotes. Int J Radiat Biol 66: 177-182, 1994.
23. Athman P, Rappaport R and Swift M: Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130-134, 1996.
24. FitzGerald M, Bean JM, Hegde SD, Unsal H, MacDonald D, Harkin DP, Finkelstein DM, Isselbacher KJ and Haber DA: Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15: 307-310, 1997.
25. Vorechovsky I, Luo L, Lindblom A, Negrini M, Webster ADB, Croce CM and Hammarström L: ATM mutations in cancer families. Cancer Res 56: 4130-4133, 1996.
26. Chessa L, Lisa A, Fiorani O and Zei G: Ataxia-telangiectasia in Italy: genetic analysis. Int J Radiat Biol 66: S31-S33, 1994.
27. Chomczyncki P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
28. Roest PAM, Roberts RG, Sugino S, van Ommen GJB and den Dunnen JT: Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet 2: 1719-1721, 1993.
29. Ponz de Leon M: Genetic predisposition and environmental factors in gastric carcinoma. In: Recent Results in Cancer Research (Familial and Hereditary Tumors). Springer-Verlag, Berlin, pp179-202, 1994.
30. Hsing AW, Hansson LE and McLaughlin JK: Pernicious anemia and subsequent cancer. Cancer 71: 745-750, 1993.
31. Macklin MT: Inheritance of cancer of the stomach and large intestin in man. J Natl Cancer Inst 24: 551-571, 1960.
32. Zanguieri G, Di Gregorio C and Sacchetti C: Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 66: 2047-2051, 1990.
33. La Vecchia C, Negri E and Franceshi S: Family history and the risk of stomach and colorectal cancer. Cancer 70: 50-55, 1992.
34. Mecklin JP and Jarvinen HJ: Tumor spectrum in cancer family syndrome. Cancer 68: 1109-1112, 1991.
35. Vorechovsy I, Rasio D, Luo L, Monaco C, Hammarström L, Webster ADB, Zaloudik J, Barbanti-Brodano G, James M, Russo G, Croce CM and Negrini M: The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56: 2726-2732, 1996.
36. Huo YK, Wang Z, Hong JH, Chessa L, McBride WH, Perlman SL and Gatti RA: Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia and related syndromes using a modified colony survival assay. Cancer Res 54: 2544-2547, 1994.
37. Hampton GM, Mannermaa A, Winqvist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee WK and Evans GA: Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res 54: 4586-4589, 1994.
38. Hampton GM, Penny LA, Baergen LN, Larson A, Brewer C, Liao S, Busby-Earle RMC, Williams AWR, Steel CM, Bird CC, Stanbridge EJ and Evans GA: Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 91: 6953-6957, 1994.
39. Davis M, Hitchcock A, Foulkes WD and Campbell IG: Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res 56: 741-744, 1996.